Aurinia Pharmaceuticals
AUPH
AUPH
73 hedge funds and large institutions have $193M invested in Aurinia Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
19
Reduced
25
Closed
11
Calls
$6.35M
Puts
$3.81M
Net Calls
+$2.54M
Net Calls Change
+$2.08M
Top Buyers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$6.15M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$4.61M |
| 3 |
O
OrbiMed
New York
|
+$2.51M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.2M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$192K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.25M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.1M |
| 3 |
Goldman Sachs
New York
|
-$1.61M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.35M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.04M |
